Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder

Background. Alcohol use disorder (AUD) incidence is increasing, and alcohol-associated liver disease is the leading indication for liver transplantation (LT) in the United States. Many centers have adopted “early LT” (ELT) for patients with <6 mo of abstinence. This study evaluates whether ELT ou...

Full description

Saved in:
Bibliographic Details
Main Authors: Andrea M. Meinders, MD, Ashton A. Connor, MD, PhD, John Ontiveros, LCSW, Ahmed Elaileh, MD, Khush Patel, MD, MS, Jason Todd, BS, MBA, Danika L. Nottage, BS, BMSc, Elizabeth W. Brombosz, PhD, Linda W. Moore, PhD, Caroline J. Simon, MD, Yee Lee Cheah, MD, Mark J. Hobeika, MD, Constance M. Mobley, MD, PhD, Ashish Saharia, MD, Tamneet Basra, MD, Sudha Kodali, MD, MSPH, David W. Victor, III, MD, Brian P. Lee, MD, Norah Terrault, MD, Xian C. Li, PhD, A. Osama Gaber, MD, R. Mark Ghobrial, MD, PhD
Format: Article
Language:English
Published: Wolters Kluwer 2025-04-01
Series:Transplantation Direct
Online Access:http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001776
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850097868511117312
author Andrea M. Meinders, MD
Ashton A. Connor, MD, PhD
John Ontiveros, LCSW
Ahmed Elaileh, MD
Khush Patel, MD, MS
Jason Todd, BS, MBA
Danika L. Nottage, BS, BMSc
Elizabeth W. Brombosz, PhD
Linda W. Moore, PhD
Caroline J. Simon, MD
Yee Lee Cheah, MD
Mark J. Hobeika, MD
Constance M. Mobley, MD, PhD
Ashish Saharia, MD
Tamneet Basra, MD
Sudha Kodali, MD, MSPH
David W. Victor, III, MD
Brian P. Lee, MD
Norah Terrault, MD
Xian C. Li, PhD
A. Osama Gaber, MD
R. Mark Ghobrial, MD, PhD
author_facet Andrea M. Meinders, MD
Ashton A. Connor, MD, PhD
John Ontiveros, LCSW
Ahmed Elaileh, MD
Khush Patel, MD, MS
Jason Todd, BS, MBA
Danika L. Nottage, BS, BMSc
Elizabeth W. Brombosz, PhD
Linda W. Moore, PhD
Caroline J. Simon, MD
Yee Lee Cheah, MD
Mark J. Hobeika, MD
Constance M. Mobley, MD, PhD
Ashish Saharia, MD
Tamneet Basra, MD
Sudha Kodali, MD, MSPH
David W. Victor, III, MD
Brian P. Lee, MD
Norah Terrault, MD
Xian C. Li, PhD
A. Osama Gaber, MD
R. Mark Ghobrial, MD, PhD
author_sort Andrea M. Meinders, MD
collection DOAJ
description Background. Alcohol use disorder (AUD) incidence is increasing, and alcohol-associated liver disease is the leading indication for liver transplantation (LT) in the United States. Many centers have adopted “early LT” (ELT) for patients with <6 mo of abstinence. This study evaluates whether ELT outcomes in acutely ill recipients are equivalent to standard LT (SLT). Methods. We retrospectively analyzed LTs for alcohol-associated liver disease in patients with AUD at a single center between January 2019 and December 2021. Patients were categorized as ELT (<6 mo) or SLT (≥6 mo). Alcohol relapse was categorized as “abstinent,” “slip,” or “harmful,” with use defined by phosphatidylethanol or self-reported consumption. Outcomes were post-LT relapse, graft, and patient survival. Results. Of 183 patients (ELT: 99 [54.1%]; SLT: 84 [45.9%]), ELT recipients were younger, had higher model for end-stage liver disease scores, shorter waitlist times, and were more frequently in intensive care unit pre-LT. Multivariable analysis showed no association in time to post-LT relapse, graft, or patient survival. Intensive care unit status was associated with lower relapse risk (hazard ratio, 0.17; 95% confidence interval, 0.07-0.43; P < 0.001), whereas higher education levels were associated with higher risk (hazard ratio, 2.31; 95% confidence interval, 1.18-4.49; P = 0.014). Conclusions. Pre-LT alcohol abstinence duration does not significantly impact post-LT relapse or survival. ELT should be considered for acutely ill patients with AUD.
format Article
id doaj-art-8ef837299e524b64a24d0506cb8604db
institution DOAJ
issn 2373-8731
language English
publishDate 2025-04-01
publisher Wolters Kluwer
record_format Article
series Transplantation Direct
spelling doaj-art-8ef837299e524b64a24d0506cb8604db2025-08-20T02:40:51ZengWolters KluwerTransplantation Direct2373-87312025-04-01114e177610.1097/TXD.0000000000001776202504000-00007Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use DisorderAndrea M. Meinders, MD0Ashton A. Connor, MD, PhD1John Ontiveros, LCSW2Ahmed Elaileh, MD3Khush Patel, MD, MS4Jason Todd, BS, MBA5Danika L. Nottage, BS, BMSc6Elizabeth W. Brombosz, PhD7Linda W. Moore, PhD8Caroline J. Simon, MD9Yee Lee Cheah, MD10Mark J. Hobeika, MD11Constance M. Mobley, MD, PhD12Ashish Saharia, MD13Tamneet Basra, MD14Sudha Kodali, MD, MSPH15David W. Victor, III, MD16Brian P. Lee, MD17Norah Terrault, MD18Xian C. Li, PhD19A. Osama Gaber, MD20R. Mark Ghobrial, MD, PhD211 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.2 J. C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX.3 Houston Methodist Academic Institute, Houston, TX.3 Houston Methodist Academic Institute, Houston, TX.3 Houston Methodist Academic Institute, Houston, TX.2 J. C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX.3 Houston Methodist Academic Institute, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.2 J. C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX.2 J. C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX.2 J. C. Walter Jr. Transplant Center, Houston Methodist Hospital, Houston, TX.6 Division of Gastroenterology and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA.6 Division of Gastroenterology and Liver Diseases, Keck School of Medicine, University of Southern California, Los Angeles, CA.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.1 Department of Surgery, Houston Methodist Hospital, Houston, TX.Background. Alcohol use disorder (AUD) incidence is increasing, and alcohol-associated liver disease is the leading indication for liver transplantation (LT) in the United States. Many centers have adopted “early LT” (ELT) for patients with <6 mo of abstinence. This study evaluates whether ELT outcomes in acutely ill recipients are equivalent to standard LT (SLT). Methods. We retrospectively analyzed LTs for alcohol-associated liver disease in patients with AUD at a single center between January 2019 and December 2021. Patients were categorized as ELT (<6 mo) or SLT (≥6 mo). Alcohol relapse was categorized as “abstinent,” “slip,” or “harmful,” with use defined by phosphatidylethanol or self-reported consumption. Outcomes were post-LT relapse, graft, and patient survival. Results. Of 183 patients (ELT: 99 [54.1%]; SLT: 84 [45.9%]), ELT recipients were younger, had higher model for end-stage liver disease scores, shorter waitlist times, and were more frequently in intensive care unit pre-LT. Multivariable analysis showed no association in time to post-LT relapse, graft, or patient survival. Intensive care unit status was associated with lower relapse risk (hazard ratio, 0.17; 95% confidence interval, 0.07-0.43; P < 0.001), whereas higher education levels were associated with higher risk (hazard ratio, 2.31; 95% confidence interval, 1.18-4.49; P = 0.014). Conclusions. Pre-LT alcohol abstinence duration does not significantly impact post-LT relapse or survival. ELT should be considered for acutely ill patients with AUD.http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001776
spellingShingle Andrea M. Meinders, MD
Ashton A. Connor, MD, PhD
John Ontiveros, LCSW
Ahmed Elaileh, MD
Khush Patel, MD, MS
Jason Todd, BS, MBA
Danika L. Nottage, BS, BMSc
Elizabeth W. Brombosz, PhD
Linda W. Moore, PhD
Caroline J. Simon, MD
Yee Lee Cheah, MD
Mark J. Hobeika, MD
Constance M. Mobley, MD, PhD
Ashish Saharia, MD
Tamneet Basra, MD
Sudha Kodali, MD, MSPH
David W. Victor, III, MD
Brian P. Lee, MD
Norah Terrault, MD
Xian C. Li, PhD
A. Osama Gaber, MD
R. Mark Ghobrial, MD, PhD
Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
Transplantation Direct
title Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
title_full Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
title_fullStr Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
title_full_unstemmed Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
title_short Outcomes for Early Liver Transplantation for Alcohol-associated Liver Disease in High-acuity Liver Transplant Recipients With Alcohol Use Disorder
title_sort outcomes for early liver transplantation for alcohol associated liver disease in high acuity liver transplant recipients with alcohol use disorder
url http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001776
work_keys_str_mv AT andreammeindersmd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT ashtonaconnormdphd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT johnontiveroslcsw outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT ahmedelailehmd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT khushpatelmdms outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT jasontoddbsmba outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT danikalnottagebsbmsc outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT elizabethwbromboszphd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT lindawmoorephd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT carolinejsimonmd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT yeeleecheahmd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT markjhobeikamd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT constancemmobleymdphd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT ashishsahariamd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT tamneetbasramd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT sudhakodalimdmsph outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT davidwvictoriiimd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT brianpleemd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT norahterraultmd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT xiancliphd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT aosamagabermd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder
AT rmarkghobrialmdphd outcomesforearlylivertransplantationforalcoholassociatedliverdiseaseinhighacuitylivertransplantrecipientswithalcoholusedisorder